Devers Eye Institute in Portland, Ore., offers its patients corneal crosslinking, a treatment designed to slow post-LASIK ectasia and keratoconus, according to The Lund Report.
Ophthalmology
IRIDEX, a Mountain View, Calif.-based ophthalmology device company, has announced a partnership with New Britain, Pa.-based Peregrine Surgical to expand its ophthalmology product portfolio.
MacuLogix, an ophthalmic diagnostics company based in Hummelstown, Pa., has announced it is aiming to raise $5 million in Series B funding, according to a DOWJONES report.
Steven Feldon, MD, the director of University of Rochester Medical Center Flaum Eye Institute, has been named president of the Association of University Professors of Ophthalmology.
Eye Excellence's Mary Green, MD, a board-certified ophthalmologist, has been received the 2012 Sightpath Top Surgeon award.
Advertisement
Bausch + Lomb's experimental glaucoma medication, BOL 303259-X, has shown a greater reduction of intraocular pressure than the current standard glaucoma treatment, latanoprost, according to a Medscape report.
The New York Ear and Eye Infirmary recently published a study showing Diopsys NOVA-LX Visual Evoked Potential Vision Testing System to be an effective tool in the early detection of glaucoma.
Calvin Christopher Brown, MD, a retinal fellow at the Eye Specialty Group in Memphis, Tenn., will be offering his services at all four San Antonio Eye Center locations.
Bausch + Lomb, leading ophthalmology company, is planning for an initial public offering of stock and intends to use the proceeds to repay a $700 million loan, according to an Optics report.
Balamurali Ambati, MD, of the University of Utah in Salt Lake City, is leading a team of researchers in the study of polymer nanoparticles as a treatment for macular degeneration, according to a report by Chemical & Engineering News.